Connect with us

Press Release

China Medical System: First Prescriptions for Innovative Drug Lumeblue® Issued in China

Published

5 months ago

on

SHENZHEN, CHINA – On 6 December, China Medical System Holdings Limited (“CMS” or the “Group”) is pleased to announce that the first prescriptions for the innovative drug Lumeblue® (Methylthioninium Chloride Enteric-coated Sustained-release Tablets) (the “Product”) have been issued in China, which marks that the first oral methylthioninium chloride enteric-coated sustained-release tablets in China has officially entered clinical application. The Product is indicated for enhancing visualization of colorectal lesions in adult patients undergoing screening or surveillance colonoscopies.

 

Lumeblue® is an oral diagnostic drug that uses patented multi-matrix (MMXTM) technology to deliver active substances directly to the colon and release them locally in a controlled manner. As an enhancer dye, the Product increases the contrast between colorectal lesions and healthy mucosa. The results of the Phase III clinical trial in China show that the Product can significantly improve the detection rate of non-polypoid colorectal lesions (the primary endpoint of the study), leading to an improved detection rate of dangerous lesions such as non-polypoid adenomas (the secondary endpoint)[1]. In addition, the Product can be taken during the bowel preparation step, ensuring that colorectal staining is completed by the time colonoscopy is conducted. This not only enhances the detection rate of colorectal lesions but also potentially simplifies the colonoscopy procedure, making the examination more efficient and improving the screening benefits.

 

According to the diagnosis and treatment data of the Digestive Endoscopy Branch of the Chinese Medical Association, approximately a total of 28 million gastroenteroscopies were completed nationwide in 2012, including 5.83 million colonoscopies. In 2019, approximately 38.73 million gastroenteroscopies were completed nationwide, an increase of 34.62% compared with 2012[2]. The Expert consensus on the early diagnosis and treatment of colorectal cancer in China (2023 edition) recommends colorectal cancer screening for individuals aged 40 to 74[3]. Based on the China Statistical Yearbook (2023), the total population of this age group in China is 643.36 million[4]. With the popularization of early colorectal cancer screening in China, the number of colonoscopies performed is expected to have significant growth potential in the future. Early diagnosis and removal of lesions are crucial for prevention. Lumeblue® provides an innovative solution for colorectal disease screening and management in response to this growing demand.

 

The Product has been approved by the European Medicines Agency (EMA) to be commercialized in the European Union under the trade name Lumeblue® in August 2020. The Group obtained an exclusive license for the Product from Cosmo Technologies Ltd., a fully-owned subsidiary of Cosmo Pharmaceuticals NV, on 3 December 2020. Following its approval in China in June 2024, CMS worked collaboratively across its business segments to ensure the rapid importation of the first batch of products. The Group has also actively leveraged its existing gastroenterology portfolio and resources to orderly advance the commercialization and academic promotion of Lumeblue®, facilitating its successful prescriptions launch in China.

 

With this milestone, CMS’s five innovative drugs have been successfully approved in China and fully entered clinical application. This achievement demonstrates the Group’s ongoing capability of innovation transformation, while reflecting CMS’s commitment to focusing on medical value and fulfilling its corporate social responsibility. Looking ahead, CMS will continue to be patients-centered, efficiently advancing the clinical development and commercialization of innovative products. The Group is dedicated to improving the accessibility and affordability of innovative drugs, benefiting a broader patient population.

 

About CMS

CMS is a platform company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability, dedicated to providing competitive products and services to meet unmet medical needs.

 

CMS focuses on the global first-in-class (FIC) and best-in-class (BIC) innovative products, and efficiently promotes the clinical research, development and commercialization of innovative products, enabling the continuous transformation of scientific research into clinical practices to benefit patients.

 

CMS deeply engages in several specialty therapeutic fields, and has developed proven commercialization capabilities, extensive networks and expert resources, resulting in leading academic and market positions for its major marketed products. CMS continues to promote the in-depth development of its advantageous specialty fields and expand business boundaries. While strengthening the competitiveness of the cardio-cerebrovascular/gastroenterology business, CMS independently operates its dermatology and medical aesthetics business, and ophthalmology business, aiming to gain leading positions in specialty therapeutic fields, whilst enhancing the scale and efficiency. At the same time, CMS has expanded its business territory to the Southeast Asian market, striving to become a “bridgehead” for global pharmaceutical companies to enter the Southeast Asian market, further escorting the sustainable and healthy development of the Group.

 

References:

CMS Disclaimer and Forward-Looking Statements

This press release is not intended to promote any products to you and is not for advertising purposes. This press release does not recommend any drugs, medical devices and/or indications. If you want to know more about the diagnosis and treatment of specific diseases, please follow the opinions or guidance of your doctor or other medical and health professionals. Any treatment-related decisions made by healthcare professionals should be based on the patient’s specific circumstances and in accordance with the drug package insert.

 

This press release which has been prepared by CMS does not constitute any offer or invitation to purchase or subscribe for any securities, and shall not form the basis for or be relied on in connection with any contract or binding commitment whatsoever. This press release has been prepared by CMS based on information and data which it considers reliable, but CMS makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this press release. Certain matters discussed in this press release may contain statements regarding the Group’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. Any forward-looking statements and projections made by third parties included in this press release are not adopted by the Group and the Company is not responsible for such third-party statements and projections.

 

 

Media Contact

Brand: China Medical System Holdings Ltd.

Contact: CMS Investor Relations

Email: ir@cms.net.cn

Website: https://web.cms.net.cn/en/home/

Source: China Medical System Holdings Ltd.

 

  1. The results of the Product’s Phase III clinical trial in China were published and are available at: https://web.cms.net.cn/en/2022/12/positive-results-for-china-phase-iii-c…
  2. Data from the Digestive Endoscopy Branch of the Chinese Medical Association
  3. Early Diagnosis and Treatment Group of the Chinese Society of Oncology. “Expert Consensus on Early Diagnosis and Treatment of Colorectal Cancer in China (2023 Edition).” Chinese Medical Journal, 2023, 103(48): 3896-3908. DOI: 10.3760/cma.j.cn112137-20230804-00164
  4. National Bureau of Statistics. (2023). China Statistical Yearbook 2023. Retrieved from https://www.stats.gov.cn/sj/ndsj/2023/indexch.htm

About Author

Cloud PR Wire

See author's posts

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Related Topics:
Continue Reading

Press Release

Safetyvalue Trading Center Launches Mobile App V2 With Biometric Login and Real-Time Alerts

Published

4 hours ago

on

April 30, 2025

By

Safetyvalue Trading Center unveils Mobile App V2, featuring biometric authentication, customizable dashboards, and push notifications to support secure, high-speed crypto trading for users around the world.

Safetyvalue Trading Center today announced the official release of Safetyvalue Mobile App V2, a major update to its iOS and Android applications that brings powerful new features, optimized performance, and improved accessibility for global cryptocurrency traders. This latest version reflects the company’s focus on delivering a streamlined, user-friendly mobile experience without compromising on security or functionality.

Safetyvalue Trading Center Launches Mobile App V2 With Biometric Login and Real-Time Alerts

The V2 upgrade introduces a redesigned interface that makes it easier for users to view markets, manage portfolios, and execute trades in just a few taps. In addition to the sleek new design, Safetyvalue has integrated biometric login options, including Face ID and fingerprint authentication, for enhanced account security and convenience.

Key upgrades include:

Biometric authentication for secure, password-free access

Customizable trading dashboard with real-time charts, order book, and price alerts

Push notifications for price movements, order execution, and system updates

NFT wallet view and direct marketplace access

One-click switching between spot, margin, and DeFi modes

Support for 10+ languages, including Spanish, Arabic, Japanese, and Portuguese

“The mobile experience is critical to modern crypto users, and V2 is designed to meet their evolving needs,” said a Safetyvalue product director. “Whether users are tracking NFT auctions, managing a diverse portfolio, or executing high-frequency trades, the new app ensures everything is accessible, fast, and secure—right from their pocket.”

The new app architecture has also been optimized for low-bandwidth environments and faster load times, especially in emerging markets. Safetyvalue has implemented advanced caching and real-time syncing mechanisms that allow users to stay connected even with intermittent internet access.

In addition to core trading features, Safetyvalue App V2 includes educational modules, how-to guides, and integrated customer support via live chat and help center browsing. This makes it easier for new users to onboard and begin trading with confidence, regardless of prior experience.

The updated mobile app plays a key role in Safetyvalue’s broader mission to provide borderless, 24/7 access to digital assets. It supports all Safetyvalue account types and integrates seamlessly with the platform’s unified multi-asset system, allowing users to manage fiat, crypto, NFTs, and DeFi positions from a single wallet interface.

App V2 is now available on the Apple App Store and Google Play, with rollout support for over 100 countries. Safetyvalue has confirmed that additional features—such as wallet connect integrations, staking dashboards, and multi-account switching—are in development for upcoming releases.

Download or learn more at:

https://safetyvalue.info

https://safetyvalue-review.com

https://safetyvaluetrading.center

https://safetyvaluetrading.pro

https://safetyvalue.wiki

Media Contact

Organization: Safetyvalue

Contact Person: Alexander Griffin

Website: https://safetyvalue.com/

Email: Send Email

Country:United States

Release id:27142

Disclaimer: The information provided in this press release is for informational purposes only and does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Safetyvalue Trading Center does not recommend that any cryptocurrency should be bought, sold, or held by you. Conduct your own due diligence and consult your financial advisor before making any investment decisions. Cryptocurrency trading involves substantial risk and may not be suitable for all investors.

View source version on King Newswire:
Safetyvalue Trading Center Launches Mobile App V2 With Biometric Login and Real-Time Alerts

It is provided by a third-party content provider. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release.

file

About Author

Cloud PR Wire

See author's posts

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

ExaCrypt Unveils Redesigned Platform Interface Focused on Usability and Speed

Published

4 hours ago

on

April 30, 2025

By

The new ExaCrypt interface introduces an upgraded, user-centered design featuring improved navigation, mobile optimization, and advanced charting tools—empowering traders with a more efficient, responsive platform.

ExaCrypt, a leading digital asset trading platform, is excited to announce the launch of its completely redesigned user interface (UI), offering a modern, intuitive, and more user-friendly experience for traders worldwide. This significant platform update is aimed at improving navigation, enhancing the overall user experience, and ensuring a more streamlined trading process for both beginners and seasoned professionals.

ExaCrypt Unveils Redesigned Platform Interface Focused on Usability and Speed

A Modern, Streamlined Design for Enhanced Trading Efficiency

The new user interface brings a fresh, modern look while maintaining the platform’s robust functionality. Key features of the redesigned UI include:

Intuitive Layout: The interface has been simplified for easier access to essential trading tools and information. Users can now quickly find the features they need, from live market data to order placement, all in one place.

Customizable Dashboard: Traders can personalize their dashboard with widgets and shortcuts to prioritize their most-used tools and data, creating a tailored experience that fits their individual trading styles.

Optimized Mobile Experience: The updated platform design is mobile-responsive, providing seamless functionality and smooth navigation on any device, allowing users to trade on the go without compromising on features or performance.

Real-Time Data and Enhanced Charting Tools: The redesigned interface includes enhanced charting tools and real-time market data for more precise analysis and better decision-making.

User-Centered Design for All Traders

“We’ve listened to feedback from our community, and this UI redesign is the result of our commitment to making ExaCrypt not just a powerful platform, but also a highly intuitive one,” said Élise Laurent, Product Manager at ExaCrypt. “Our goal is to ensure that traders of all levels, from beginners to professionals, can easily access the tools they need to succeed. The new interface delivers on that promise, providing a clean, customizable workspace with everything traders need right at their fingertips.”

Improved Performance and Speed

Alongside the visual improvements, the platform has been optimized for performance, ensuring that users experience faster load times, smoother navigation, and improved responsiveness. This update enables ExaCrypt to continue delivering the seamless and secure trading experience that its users expect.

About ExaCrypt

ExaCrypt continues to innovate and lead in the digital asset trading industry by providing advanced tools, a secure environment, and a user-focused platform. With the launch of the new UI, ExaCrypt further strengthens its commitment to offering a top-tier, user-friendly platform that empowers traders around the world.

For more information, please visit:

https://www.exacrypt.review

https://www.exacrypt.pro

https://www.exacrypt-fr.com

 

Disclaimer: The information provided in this press release is not a solicitation for investment, nor is it intended as investment advice, financial advice, or trading advice. It is strongly recommended you practice due diligence, including consultation with a professional financial advisor, before investing in or trading cryptocurrency and securities.

Media Contact

Organization: ExaCrypt

Contact Person: Elise Laurent

Website: https://e-crypt.com/

Email: Send Email

City: Paris

Country:France

Release id:27137

View source version on King Newswire:
ExaCrypt Unveils Redesigned Platform Interface Focused on Usability and Speed

It is provided by a third-party content provider. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release.

file

About Author

Cloud PR Wire

See author's posts

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

24Newswire.com Sets the Gold Standard in Press Release Distribution with Unmatched Reach and Results

Published

4 hours ago

on

April 30, 2025

By

24Newswire.com delivers reliable and results-driven press release distribution services for businesses of all sizes. From corporate announcements to event promotions, the platform makes it easy to distribute press releases to thousands of top-tier media outlets worldwide. Designed for maximum visibility and brand impact, 24Newswire offers strategic targeting, real-time reporting, and one of the most effective solutions for business PR distribution and event news distribution available today.

New York, NY – In today’s fast-paced digital age, getting noticed is more challenging than ever. Enter 24Newswire.com, a leading platform revolutionizing the way businesses and organizations distribute press releases. Offering one of the best press release distribution services in the industry, 24Newswire.com is designed to amplify visibility, increase brand credibility, and reach global audiences through powerful media networks.

As a premier press release distribution service, 24Newswire.com enables clients to seamlessly submit their press release for distribution across 15,000+ news outlets, including prominent platforms such as Google News, Yahoo Finance, AP News, MarketWatch, and more. Whether you’re a startup launching a product or a multinational company making major announcements, 24Newswire.com ensures your message reaches the right audience.

 

Why Choose 24Newswire.com?

Best Press Release Distribution Services: At 24Newswire.com, we pride ourselves on being among the best press release distribution platforms globally. Our platform provides industry-leading exposure by tapping into targeted and authoritative media outlets.

Business PR Distribution: For companies looking to build strong brand awareness or make impactful announcements, our Business PR Distribution services are tailored to deliver measurable results. From investor relations to product launches, 24Newswire covers it all.

Event News Distribution: Planning an event? 24Newswire specializes in Event News Distribution, helping organizers attract media attention and maximize event attendance through timely and widespread media coverage.

How Are Press Releases Distributed?

Many businesses often ask, “how are press releases distributed?” The answer lies in a combination of strategic syndication and cutting-edge technology. 24Newswire uses a robust network of journalists, bloggers, newsrooms, and online publishers to ensure every press release for distribution reaches its maximum potential.

Our streamlined system allows users to easily upload, format, and distribute press releases within minutes. Coupled with advanced targeting options and analytics, clients gain insights into reach, engagement, and media pickups.

How to Press Release Distribution – Made Simple

Still wondering “how to press release distribution” effectively? 24Newswire.com makes it simple. Just choose your package, submit your content, and we take care of the rest—from editorial review to global distribution. Our user-friendly interface is perfect for both PR professionals and first-time users.

Built for Businesses of All Sizes

Whether you’re a small business looking for cost-effective exposure or a large corporation seeking extensive media reach, 24Newswire offers flexible pricing and distribution packages to suit your needs. With scalable options and real-time analytics, our platform ensures transparency and performance tracking at every stage.

About 24Newswire.com

24Newswire.com is a trusted name in press release distribution services, helping brands, agencies, and organizations across industries communicate their stories to the world. Backed by a team of seasoned PR professionals and cutting-edge technology, 24Newswire delivers comprehensive distribution, maximum media exposure, and tangible results.

file

About Author

Cloud PR Wire

See author's posts

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

LATEST POST

Like Us
Follow Us
Subscribe Us
Follow Us